Qiagen (QGEN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $46.13, -0.09% vs the prior close of $46.17.
- Volume 2.00M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
QGEN ends flat (-0.1%) to $46.13. Closed at $46.13, -0.09% vs the prior close of $46.17. Day range $45.97–$46.74, opened at $46.59.
QGEN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — QGEN ends flat (-0.1%) to $46.13
- Closed at $46.13, -0.09% vs the prior close of $46.17. Day range $45.97–$46.74, opened at $46.59.
- Volume was 2.00M shares, 0.8x its 50-day average of 2.54M.
- Price is +5.3% vs its 50-day average ($43.81) and +8.7% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 54% of that range, 20.2% below the 52-week high.
Oct 15, 2026 — QGEN rises 1.3% to $46.17, a 6-month high, 3 up days in a row
- Closed at $46.17, +1.34% vs the prior close of $45.56. Day range $45.60–$46.49, opened at $45.96.
- Volume was 1.31M shares, 0.5x its 50-day average of 2.56M — lighter than usual.
- Price is +5.6% vs its 50-day average ($43.72) and +8.8% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 54% of that range, 20.1% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — QGEN ends flat (+0.3%) to $45.56
- Closed at $45.56, +0.26% vs the prior close of $45.44. Day range $45.47–$46.37, opened at $45.89.
- Volume was 1.63M shares, 0.6x its 50-day average of 2.59M.
- Price is +4.4% vs its 50-day average ($43.63) and +7.3% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 52% of that range, 21.2% below the 52-week high.
Oct 13, 2026 — QGEN ends flat (+0.3%) to $45.44
- Closed at $45.44, +0.29% vs the prior close of $45.31. Day range $44.97–$45.79, opened at $45.77.
- Volume was 1.44M shares, 0.6x its 50-day average of 2.61M — lighter than usual.
- Price is +4.3% vs its 50-day average ($43.57) and +7.1% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 51% of that range, 21.4% below the 52-week high.
Oct 12, 2026 — QGEN ends flat (-0.2%) to $45.31
- Closed at $45.31, -0.15% vs the prior close of $45.38. Day range $44.96–$45.69, opened at $45.68.
- Volume was 1.17M shares, 0.4x its 50-day average of 2.61M — lighter than usual.
- Price is +4.1% vs its 50-day average ($43.51) and +6.7% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 51% of that range, 21.6% below the 52-week high.
Oct 9, 2026 — QGEN rises 1.9% to $45.38
- Closed at $45.38, +1.91% vs the prior close of $44.53. Day range $44.79–$45.61, opened at $44.99.
- Volume was 1.26M shares, 0.5x its 50-day average of 2.65M — lighter than usual.
- Price is +4.5% vs its 50-day average ($43.43) and +6.9% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 51% of that range, 21.5% below the 52-week high.
Oct 8, 2026 — QGEN dips 0.6% to $44.53, 3 down days in a row
- Closed at $44.53, -0.58% vs the prior close of $44.79. Day range $43.65–$44.80, opened at $44.44.
- Volume was 1.56M shares, 0.6x its 50-day average of 2.64M — lighter than usual.
- Price is +2.7% vs its 50-day average ($43.35) and +4.9% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 47% of that range, 23.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — QGEN dips 1.9% to $44.79
- Closed at $44.79, -1.88% vs the prior close of $45.65. Day range $44.78–$46.09, opened at $45.61.
- Volume was 2.58M shares, 1.0x its 50-day average of 2.63M.
- Price is +3.5% vs its 50-day average ($43.30) and +5.5% vs its 200-day average ($42.46).
- 52-week range $32.53–$57.82; today's close sits at 48% of that range, 22.5% below the 52-week high.
Oct 6, 2026 — QGEN dips 0.3% to $45.65
- Closed at $45.65, -0.31% vs the prior close of $45.79. Day range $45.27–$47.28, opened at $47.25.
- Volume was 2.90M shares, 1.1x its 50-day average of 2.61M.
- Price is +5.6% vs its 50-day average ($43.25) and +7.5% vs its 200-day average ($42.46).
- 52-week range $32.53–$57.82; today's close sits at 52% of that range, 21.0% below the 52-week high.
Oct 5, 2026 — QGEN rises 2.3% to $45.79, a 6-month high
- Closed at $45.79, +2.32% vs the prior close of $44.75. Day range $44.46–$46.01, opened at $44.78.
- Volume was 3.05M shares, 1.2x its 50-day average of 2.58M.
- Price is +6.1% vs its 50-day average ($43.15) and +7.9% vs its 200-day average ($42.46).
- 52-week range $32.53–$57.82; today's close sits at 52% of that range, 20.8% below the 52-week high.
Oct 2, 2026 — QGEN jumps 6.4% to $44.75
- Closed at $44.75, +6.45% vs the prior close of $42.04. Day range $42.18–$45.60, opened at $42.45.
- Volume was 4.56M shares, 1.8x its 50-day average of 2.55M.
- Price is +3.9% vs its 50-day average ($43.07) and +5.4% vs its 200-day average ($42.45).
- 52-week range $32.53–$57.82; today's close sits at 48% of that range, 22.6% below the 52-week high.
QGEN latest news & SEC filings
Every SEC filing by or about QGEN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade QGEN
- How much it moves: over the last 20 sessions the average daily move was 1.64% (largest 6.4%).
- Liquidity: about 2.24M shares (≈$103.36M) trade per day on average.
- 52-week position: $46.13 vs a range of $32.53–$57.82 (54% of the range).
- Dividends: last ex-dividend date Jul 7, 2026 ($0.35/share); 1 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 9, 2026; 6-K Aug 7, 2026; 6-K Aug 7, 2026.
- Listing: NYSE · industry: Biological Products, (No Diagnostic Substances).
QGEN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 46.59 | 46.74 | 45.97 | 46.13 | 2.00M |
| Oct 15, 2026 | 45.96 | 46.49 | 45.60 | 46.17 | 1.31M |
| Oct 14, 2026 | 45.89 | 46.37 | 45.47 | 45.56 | 1.63M |
| Oct 13, 2026 | 45.77 | 45.79 | 44.97 | 45.44 | 1.44M |
| Oct 12, 2026 | 45.68 | 45.69 | 44.96 | 45.31 | 1.17M |
| Oct 9, 2026 | 44.99 | 45.61 | 44.79 | 45.38 | 1.26M |
| Oct 8, 2026 | 44.44 | 44.80 | 43.65 | 44.53 | 1.56M |
| Oct 7, 2026 | 45.61 | 46.09 | 44.78 | 44.79 | 2.58M |
| Oct 6, 2026 | 47.25 | 47.28 | 45.27 | 45.65 | 2.90M |
| Oct 5, 2026 | 44.78 | 46.01 | 44.46 | 45.79 | 3.05M |
| Oct 2, 2026 | 42.45 | 45.60 | 42.18 | 44.75 | 4.56M |
| Oct 1, 2026 | 43.85 | 43.87 | 41.94 | 42.04 | 2.62M |
| Sep 30, 2026 | 44.40 | 44.70 | 43.76 | 43.76 | 2.32M |
| Sep 29, 2026 | 44.08 | 44.66 | 44.04 | 44.40 | 4.23M |
| Sep 28, 2026 | 44.65 | 45.53 | 44.37 | 45.01 | 2.75M |
| Sep 25, 2026 | 44.73 | 44.80 | 44.00 | 44.18 | 1.41M |
| Sep 24, 2026 | 44.08 | 45.21 | 44.00 | 44.56 | 1.69M |
| Sep 23, 2026 | 43.49 | 43.92 | 42.56 | 43.71 | 3.04M |
| Sep 22, 2026 | 44.43 | 44.47 | 43.62 | 43.69 | 1.45M |
| Sep 21, 2026 | 44.48 | 44.82 | 43.99 | 44.78 | 1.86M |
About Qiagen
Qiagen (QGEN) is listed on the NYSE and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in PL VENLO. State of incorporation: Netherlands. Fiscal year ends December 31. SEC CIK 1015820.
QGEN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
QGEN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
QGEN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on QGEN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.